Skip to content

Improve your immunity with Haritaki

Immunomodulatory effect of Ritu Haritaki with madhu in healthy individual during the Vasant Ritu A randomized control trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079762
Enrollment
60
Registered
2025-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Tanuja Sagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers of either sex in the age group 18-30 years Participants willing to give written consent

Exclusion criteria

Exclusion criteria: 1 Patients with concurrent Hepatic Dysfunction or Renal Dysfunction uncontrolled Pulmonary Dysfunction or major systemic illness necessitating long term drug treatment or known cases of malignancy 2 Women who are planning for conception or pregnant or lactating history of hypersensitivity to any of the trial drugs or their ingredients Patient taking participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Changes from baseline measurements in IgG antibody investigation after taking Haritaki ChurnaTimepoint: 0, 20th, 40th, 60th

Secondary

MeasureTime frame
Improvement in WHO quality of life scale, Changes in BMI, WeightTimepoint: 0, 20th, 40th, 60th

Countries

India

Contacts

Public ContactProf Dr Unnikrishnan S

Ch Brahm Prakash Ayurved Charak Sansthan

drunnikrishnans@gmail.com9540265445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026